[Value of neoadjuvant radiochemotherapy in undifferentiated soft tissue sarcomas].
Stuschke
M
M
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000627:therapeutic use*; D007263:Infusions, Parenteral; D008875:Middle Aged; D011879:Radiotherapy Dosage; D012509:Sarcoma / Q000188:drug therapy* / Q000532:radiotherapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D004317:Doxorubicin; D002945:Cisplatin; D007069:Ifosfamide
Stellenwert der neoadjuvanten Radiochemotherapie bei undifferenzierten Weichteilsarkomen.